NI201000134A - Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. - Google Patents
Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.Info
- Publication number
- NI201000134A NI201000134A NI201000134A NI201000134A NI201000134A NI 201000134 A NI201000134 A NI 201000134A NI 201000134 A NI201000134 A NI 201000134A NI 201000134 A NI201000134 A NI 201000134A NI 201000134 A NI201000134 A NI 201000134A
- Authority
- NI
- Nicaragua
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- preparation procedure
- new
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Storage Device Security (AREA)
- Computer And Data Communications (AREA)
Abstract
Compuestos de fórmula (I): en la que : m y n representan 1 ó 2; A representa un grupo pirrolilo; X representa el grupo C(O), S(O) o SO2; R1 y R2 representan un grupo alquilo, o forman junto con el átomo de nitrógeno al que están unidos un grupo heterociclico; R3 y 114 forman junto con los átomos a los que están unidos un grupo heterocíclico; R5 representa un átomo de hidrógeno o un grupo alquilo; R6 representa un átomo de hidrógeno o un átomo de halógeno, Medicamentos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0903839A FR2948940B1 (fr) | 2009-08-04 | 2009-08-04 | Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NI201000134A true NI201000134A (es) | 2014-02-11 |
Family
ID=41796204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NI201000134A NI201000134A (es) | 2009-08-04 | 2010-08-03 | Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. |
Country Status (43)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2948940B1 (fr) | 2009-08-04 | 2011-07-22 | Servier Lab | Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| FR3008411B1 (fr) * | 2013-07-12 | 2015-07-03 | Servier Lab | Nouveau sel de la 3-[(3-{[4-(4-morpholinylmethyl)-1h-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1h-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, sa preparation, et les formulations qui le contiennent |
| US10245270B2 (en) * | 2013-07-12 | 2019-04-02 | Les Laboratoires Servier | Salt of 3-[(3-{[4-(4-morpholinylmethyl)-1H-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1H-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione, its preparation, and formulations containing it |
| JP6156845B2 (ja) * | 2014-03-04 | 2017-07-05 | 株式会社島津製作所 | マトリックス支援レーザ脱離イオン化質量分析用マトリックス |
| FR3039401B1 (fr) * | 2015-07-31 | 2018-07-13 | Les Laboratoires Servier | Nouvelle association entre le 3-[(3-{[4-(4-morpholinylmethyl)-1h-pyrrol-2-yl]methylene}-2-oxo-2,3-dihydro-1h-indol-5-yl)methyl]-1,3-thiazolidine-2,4-dione et un inhibiteur de la tyr kinase du egfr |
| US10343991B2 (en) * | 2016-11-02 | 2019-07-09 | Council Of Scientific & Industrial Research | C5, C6 substituted and/or fused oxindoles as anti-cancer agents and process for preparation thereof |
| US11897867B2 (en) | 2017-08-04 | 2024-02-13 | Bayer Aktiengesellschaft | 6-phenyl-4,5-dihydropyridazin-3(2H)-one derivatives as PDE3A and PDE3B inhibitors for treating cancer |
| JOP20200024A1 (ar) * | 2017-08-04 | 2020-02-02 | Bayer Ag | مركبات ثنائي هيدروكساديازينون |
| CN113845524B (zh) * | 2021-10-29 | 2023-11-07 | 四川农业大学 | 一种螺吡咯吲哚酮类化合物及其制备方法和应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0892248A (ja) * | 1994-09-26 | 1996-04-09 | Yamanouchi Pharmaceut Co Ltd | インドリノン誘導体 |
| AU5468499A (en) * | 1998-08-04 | 2000-02-28 | Sugen, Inc. | 3-methylidenyl-2-indolinone modulators of protein kinase |
| CN1138773C (zh) * | 1998-12-17 | 2004-02-18 | 霍夫曼-拉罗奇有限公司 | 4-链烯基(和炔基)氧吲哚作为细胞周期蛋白-依赖性激酶尤其是cdk2的抑制剂 |
| CA2377513A1 (en) | 1999-06-25 | 2001-01-04 | Universitat Zurich | Hetero-associating coiled-coil peptides |
| ATE369359T1 (de) * | 2000-02-15 | 2007-08-15 | Sugen Inc | Pyrrol substituierte indolin-2-on protein kinase inhibitoren |
| AR042586A1 (es) * | 2001-02-15 | 2005-06-29 | Sugen Inc | 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa |
| CA2470480C (en) * | 2001-12-27 | 2010-12-14 | Theravance, Inc. | Indolinone derivatives useful as protein kinase inhibitors |
| US7012088B2 (en) * | 2003-02-24 | 2006-03-14 | Pharmacia & Upjohn Company | Indolone oxazolidinones and derivatives thereof |
| AU2004284084A1 (en) * | 2003-10-24 | 2005-05-06 | Schering Aktiengesellschaft | Indolinone derivatives and their use in treating disease-states such as cancer |
| US7378530B2 (en) | 2005-02-22 | 2008-05-27 | Nereus Pharmaceuticals, Inc. | Anti-cancer and anti-microbial 5-membered heterocyclic compounds |
| KR20080083341A (ko) * | 2005-12-29 | 2008-09-17 | 더 스크립스 리서치 인스티튜트 | 인돌리논의 아미노산 유도체 기재의 단백질 키나제 억제제 |
| FR2948940B1 (fr) | 2009-08-04 | 2011-07-22 | Servier Lab | Nouveaux derives dihydroindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
2009
- 2009-08-04 FR FR0903839A patent/FR2948940B1/fr not_active Expired - Fee Related
-
2010
- 2010-07-21 PE PE2010000465A patent/PE20110206A1/es active IP Right Grant
- 2010-07-22 UY UY0001032801A patent/UY32801A/es not_active Application Discontinuation
- 2010-07-23 SG SG201005343-7A patent/SG168499A1/en unknown
- 2010-07-23 AU AU2010203305A patent/AU2010203305B2/en not_active Ceased
- 2010-07-23 MY MYPI2010003506A patent/MY183326A/en unknown
- 2010-07-23 CO CO10090014A patent/CO6320143A1/es not_active Application Discontinuation
- 2010-07-23 NZ NZ586993A patent/NZ586993A/en not_active IP Right Cessation
- 2010-07-25 JO JO2010262A patent/JO2808B1/en active
- 2010-07-25 IL IL207183A patent/IL207183A/en not_active IP Right Cessation
- 2010-07-26 AP AP2010005343A patent/AP2756A/xx active
- 2010-07-28 CA CA2710224A patent/CA2710224C/fr not_active Expired - Fee Related
- 2010-07-28 CL CL2010000804A patent/CL2010000804A1/es unknown
- 2010-07-29 ZA ZA2010/05424A patent/ZA201005424B/en unknown
- 2010-07-30 AR ARP100102775A patent/AR077510A1/es active IP Right Grant
- 2010-07-30 GE GEAP201011902A patent/GEP20125548B/en unknown
- 2010-08-02 CU CU2010000157A patent/CU23921B1/es active IP Right Grant
- 2010-08-02 MA MA33053A patent/MA32184B1/fr unknown
- 2010-08-02 UA UAA201009661A patent/UA105357C2/uk unknown
- 2010-08-03 JP JP2010174734A patent/JP5475588B2/ja not_active Expired - Fee Related
- 2010-08-03 CN CN201010246097.6A patent/CN101987848B/zh not_active Expired - Fee Related
- 2010-08-03 BR BRPI1003241-0A patent/BRPI1003241A2/pt not_active Application Discontinuation
- 2010-08-03 EP EP10290436A patent/EP2281822B1/fr active Active
- 2010-08-03 ES ES10290436T patent/ES2403227T3/es active Active
- 2010-08-03 SA SA110310634A patent/SA110310634B1/ar unknown
- 2010-08-03 HN HN2010001537A patent/HN2010001537A/es unknown
- 2010-08-03 EA EA201001087A patent/EA019481B1/ru not_active IP Right Cessation
- 2010-08-03 PL PL10290436T patent/PL2281822T3/pl unknown
- 2010-08-03 WO PCT/FR2010/000560 patent/WO2011015728A1/fr active Application Filing
- 2010-08-03 TW TW099125790A patent/TWI408138B/zh not_active IP Right Cessation
- 2010-08-03 EC EC2010010380A patent/ECSP10010380A/es unknown
- 2010-08-03 RS RS20130099A patent/RS52701B/en unknown
- 2010-08-03 NI NI201000134A patent/NI201000134A/es unknown
- 2010-08-03 ME MEP-2013-33A patent/ME01491B/me unknown
- 2010-08-03 DK DK10290436.4T patent/DK2281822T3/da active
- 2010-08-03 PT PT102904364T patent/PT2281822E/pt unknown
- 2010-08-03 KR KR1020100074879A patent/KR101309101B1/ko active IP Right Grant
- 2010-08-03 SI SI201030147T patent/SI2281822T1/sl unknown
- 2010-08-04 US US12/806,045 patent/US8133889B2/en not_active Expired - Fee Related
- 2010-08-04 MX MX2010008557A patent/MX2010008557A/es active IP Right Grant
-
2011
- 2011-09-22 HK HK11110000.4A patent/HK1155742A1/xx not_active IP Right Cessation
- 2011-11-02 US US13/373,016 patent/US8541412B2/en not_active Expired - Fee Related
-
2013
- 2013-02-13 JP JP2013025505A patent/JP5538580B2/ja not_active Expired - Fee Related
- 2013-02-21 US US13/772,984 patent/US8653073B2/en not_active Expired - Fee Related
- 2013-04-04 CY CY20131100282T patent/CY1113914T1/el unknown
- 2013-04-10 HR HRP20130327AT patent/HRP20130327T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NI201000134A (es) | Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| ECSP099216A (es) | Nuevos derivados de diosmetina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| EA200701176A1 (ru) | Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их | |
| AR089774A1 (es) | Derivados de indolizina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| NI201200191A (es) | Derivados de indolizina, su procedimiento de preparación y su aplicación en terapéutica | |
| CU24030B1 (es) | Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmacéuticas que los contienen | |
| PA8795301A1 (es) | Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen | |
| SV2009003348A (es) | Nuevos derivados triciclicos, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen | |
| AR066605A1 (es) | Derivados de heteroarilamida pirimidona | |
| CO6290668A2 (es) | Derivados de 1-oxo-1,2-dihidroisoquinolein-5-carboxamidas y de 4-oxo-3,4-dihifroquinazolina -8-carboxamidas su preparacion y su aplicacion en terapeutica | |
| AR061740A1 (es) | Nuevos derivados naftalenicos, su procedimiento de praparacion y las composiciones farmaceuticas que los contienen | |
| ECSP10010357A (es) | Nuevos derivados croménicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| CU20130037A7 (es) | Nuevos derivados dihidrobenzoxatiazepinas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| UY33927A (es) | Nuevos derivados dihidro-oxazolobenzodiazepinonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| UY32702A (es) | Nuevos derivados de ácido 2-mercaptociclopentanocarboxílico, su procedimiento de preparación y las composiciones farmacéuticas que los contienen. | |
| CR20110306A (es) | Derivados de morfina-6-glucuronido, su preparación y su aplicación en terapéutica | |
| AR061741A1 (es) | Nuevos derivados naftalenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| CR11599A (es) | Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| UY32895A (es) | Derivados acetilénicos de 5-fenilpirazolopiridina, su preparación y su aplicación terapéutica | |
| TN2010000350A1 (en) | New dihydroindolone compounds a process for their preparation and pharmaceutical compositions containing them | |
| CU20070216A7 (es) | Derivados de indanil-piperazinas, su procedimiento de preparación y las composiciones farmacéuticas que lo contienen |